These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17514879)

  • 21. Synergistic antifibrinolytic action of the potato protease inhibitor and epsilon-aminocaproic acid.
    Worowski K
    Acta Biol Acad Sci Hung; 1976; 27(2-3):125-8. PubMed ID: 140568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antifibrinolytic agents on the life span of fibrin sealant.
    Pipan CM; Glasheen WP; Matthew TL; Gonias SL; Hwang LJ; Jane JA; Spotnitz WD
    J Surg Res; 1992 Oct; 53(4):402-7. PubMed ID: 1383616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of the effect of the thymus preparations thymoptin and thymalin on fibrin-monomer polymerization].
    Pastorova VE; Liapina LA; Ashmarin IP; Kudriashov BA; Zazhireĭ VD
    Farmakol Toksikol; 1989; 52(2):47-50. PubMed ID: 2744143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of sigma-aminocaproic acid on blood coagulation and its fibrinolytic activity in vitro].
    Skipetrov VP; Bobrenko GV; Vashchenko TN; Simonova GP
    Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):39-42. PubMed ID: 5471517
    [No Abstract]   [Full Text] [Related]  

  • 25. [Problems of directed hemostasis and coagulation stimulation in pathological tendency to bleed].
    Zürn H
    Dtsch Gesundheitsw; 1969 Dec; 24(50):2353-60. PubMed ID: 4915757
    [No Abstract]   [Full Text] [Related]  

  • 26. Modifications of bleeding time and intensity of prothrombin consumption and of fibrinolysis in rats after administration of platelet extracts alone and with antifibrinolytic agents.
    De Nicola P; Lüscher EF; Soardi F; Gibelli A; Cipolli PL
    Farmaco Sci; 1967 Aug; 22(8):627-40. PubMed ID: 6077137
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombin generation and fibrin clot structure.
    Wolberg AS
    Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative studies on the fibrinolysis inhibitors AMCHA, epsilon-ACA and PAMBA].
    Fischer M
    Wien Z Inn Med; 1966 Apr; 47(4):143-53. PubMed ID: 6005160
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of epsilon-aminocaproic acid in horses.
    Ross J; Dallap BL; Dolente BA; Sweeney RW
    Am J Vet Res; 2007 Sep; 68(9):1016-21. PubMed ID: 17764418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of epsilon-aminocaproylaminoacids on prothrombin activation and thrombin activity.
    Midura-Nowaczek K; Roszkowska-Jakimiec W; Bruzgo I; Worowski K
    Mater Med Pol; 1998; 30(1-2):3-5. PubMed ID: 10214467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On the influence of protease inhibitors and synthetic antifibrinolytic agents on the bleeding time].
    Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):174-8. PubMed ID: 4174655
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the anticoagulant effect of some inhibitors of fibrinolysis].
    Donner L; Housková J
    Sb Lek; 1969 Apr; 71(4):85-91. PubMed ID: 5305357
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of short peptides containing lysine and epsilon-aminocaproic acid on fibrinolytic activity of plasmin and topoisomerase II action on supercoiled DNA.
    Midura-Nowaczek K; Purwin M; Markowska A; Drozdowska D; Bruzgo M
    Acta Pol Pharm; 2013; 70(3):431-4. PubMed ID: 23757933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On the effect of various antifibrinolytic agents on blood coagulation].
    Gerl D; Bonow A
    Med Klin; 1969 Feb; 64(9):374-8. PubMed ID: 5783025
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of ε-aminocaproyl-S-benzyl-L-cysteine on the t-PA activity of human saliva.
    Midura-Nowaczek K; Kaczyńska J; Bruzgo I; Markowska A; Drozdowska D
    Adv Med Sci; 2011; 56(2):323-6. PubMed ID: 22037173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative monitoring of intravascular coagulation and fibrinolysis in the lungs of rats.
    Coombey D; Tyler HM
    Thromb Diath Haemorrh; 1972 Apr; 27(2):241-5. PubMed ID: 5049613
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of some epsilon-aminocaproic acid derivatives on platelet responses.
    Bruzgo I; Tomasiak M; Stelmach H; Midura-Nowaczek K
    Acta Biochim Pol; 2004; 51(1):73-80. PubMed ID: 15094827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CU-2010--a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties.
    Dietrich W; Nicklisch S; Koster A; Spannagl M; Giersiefen H; van de Locht A
    Anesthesiology; 2009 Jan; 110(1):123-30. PubMed ID: 19104179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antiplasmins].
    Enache F; Cecil P
    Med Interna (Bucur); 1970 Jun; 22(6):667-76. PubMed ID: 4917257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.